Akums Drugs and Pharmaceuticals Reports 35.4 Percent EBITDA Growth in Q1 FY27
Akums Drugs and Pharmaceuticals starts FY27 on a strong note, reporting robust revenue, EBITDA and PAT growth as its CDMO business continues to drive performance.
Pharmaceutical Customers | 11/08/2026 | By News Bureau
Hikal Commissions Enhanced cGMP Pilot Plant at Pune R&T Campus
Hikal has commissioned an upgraded cGMP-compliant pilot plant at its Pune Research and Technology campus, expanding its capabilities in process development, technology transfer and clinical-stage manufacturing.
Pharmaceutical Customers | 22/07/2026 | By News Bureau | 108
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy